Acceptability and feasibility of fecal microBIOME and serum metabolite sample collection in people with end-stage kidney disease and pain being treated with HemoDialysis: A pilot study (BIOME-HDp)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Acceptability and feasibility of fecal microBIOME and serum metabolite sample collection in people with end-stage kidney disease and pain being treated with HemoDialysis: A pilot study (BIOME-HDp)

Published:2022-10 Issue: Volume:29 Page:100995
ISSN:2451-8654
Container-title:Contemporary Clinical Trials Communications
language:en
Short-container-title:Contemporary Clinical Trials Communications

Author:

Lockwood Mark B.^ORCID,Fischer Michael J.,Silva Kimberly^ORCID,Contreras Blanca N.,Zamora Guillermo,Goldstein Amanda,Meinel Monya,Holden Christopher,Lash James,Steffens Alana,Doorenbos Ardith

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference64 articles.

1. Quality of life in patients with end-stage renal disease treated with hemodialysis: survival is not enough;Kimmel;J. Nephrol.,2008

2. Pain in hemodialysis patients: prevalence, cause, severity, and management;Davison;Am. J. Kidney Dis.,2003

3. Opioid prescription, morbidity, and mortality in United States dialysis patients;Kimmel;J. Am. Soc. Nephrol.,2017

4. Opioid and benzodiazepine use in end-stage renal disease: a systematic review;Wyne;Clin. J. Am. Soc. Nephrol. : CJASN,2011

5. The role of opioids in pain management in elderly patients with chronic kidney disease: a review article;Dolati;Anesthesiol. Pain Med.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP